Clinical Outcomes of Patients With Diabetic Nephropathy Randomized to Clopidogrel Plus Aspirin Versus Aspirin Alone (A post hoc Analysis of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance [CHARISMA] Trial)

1996, A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE), Lancet, 348, 1329, 10.1016/S0140-6736(96)09457-3 Gawaz, 1994, Changes in platelet membrane glycoproteins and platelet-leukocyte interaction during hemodialysis, Clin Invest, 72, 424, 10.1007/BF00180515 Best, 2008, The efficacy and safety of long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: results from the Clopidogrel for the Reduction of Events During Observation Trial (CREDO) Trial, Am Heart J, 155, 687, 10.1016/j.ahj.2007.10.046 Keltai, 2007, Renal function and outcomes in acute coronary syndrome: impact of clopidogrel, Eur J Cardiovasc Prev Rehabil, 14, 312, 10.1097/01.hjr.0000220582.19516.a6 Bhatt, 2006, Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events, N Engl J Med, 354, 1706, 10.1056/NEJMoa060989 1993, An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction, N Engl J Med, 329, 673, 10.1056/NEJM199309023291001 Cannon, 2000, Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) Trial, Circulation, 102, 149, 10.1161/01.CIR.102.2.149 Farid, 2007, Cytochrome P450 3A inhibition by ketoconazole affects prasugrel and clopidogrel pharmacokinetics and pharmacodynamics differently, Clin Pharmacol Ther, 81, 735, 10.1038/sj.clpt.6100139 Touchette, 1991, The effect of renal failure on hepatic drug clearance, DICP, 25, 1214, 10.1177/106002809102501111 Talbert, 1994, Drug dosing in renal insufficiency, J Clin Pharmacol, 34, 99, 10.1002/j.1552-4604.1994.tb03973.x Leblond, 2001, Downregulation of hepatic cytochrome P450 in chronic renal failure, J Am Soc Nephrol, 12, 326, 10.1681/ASN.V122326 Konishi, 1986, Pharmacokinetics of cefmenoxime in patients with impaired renal function and in those undergoing hemodialysis, Antimicrob Agents Chemother, 30, 901, 10.1128/AAC.30.6.901 Waehre, 2006, Clopidogrel increases expression of chemokines in peripheral blood mononuclear cells in patients with coronary artery disease: results of a double-blind placebo-controlled study, J Thromb Haemost, 4, 2140, 10.1111/j.1538-7836.2006.02131.x Steinhubl, 2007, Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease, Vasc Med, 12, 113, 10.1177/1358863X07077462 Szalai, 2001, Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD), Atherosclerosis, 158, 233, 10.1016/S0021-9150(01)00423-3